Xanomeline Tartrate is a muscarinic acetylcholine receptor agonist that functions by selectively activating central M1 and M4 receptor subtypes. Approved as part of a fixed-dose combination therapy for… Read more
Xanomeline Tartrate is a muscarinic acetylcholine receptor agonist that functions by selectively activating central M1 and M4 receptor subtypes. Approved as part of a fixed-dose combination therapy for the treatment of schizophrenia, this agent offers a novel mechanism distinct from traditional dopamine-based antipsychotics. The catalogue features a comprehensive selection of related materials, including identified impurities, metabolites, and stable isotope-labelled compounds. These reference standards are essential for pharmaceutical laboratories engaged in rigorous analytical testing, impurity profiling, and method validation. By utilizing these precisely characterized materials, researchers can ensure accurate quantification and qualitative identification during quality control procedures. These standards support the development of robust analytical methods, facilitating reliable results in bioanalytical studies and ensuring compliance with regulatory requirements throughout the pharmaceutical product lifecycle.